1,036 followers
Our paper looking at the use of #monoclonalantibodies for the reduction of symptom burden in #longcovid #pasc was published today! https://t.co/Zaa71HNsnF Good reduction in symptom, faster recovery time, and improved quality of life in the mAbs group. @In